Verified peer comparison
Amentum Holdings, Inc. Common Stock vs Regeneron Pharmaceuticals, Inc. Financial Comparison
Amentum Holdings, Inc. Common Stock versus Regeneron Pharmaceuticals, Inc. usin…
Direct answer
Amentum Holdings, Inc. Common Stock and Regeneron Pharmaceuticals, Inc. are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Amentum Holdings, Inc. Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Amentum Holdings, Inc. Common Stock Revenue
- 14,393,000,000 USD
- Regeneron Pharmaceuticals, Inc. Revenue
- 14,342,900,000 USD
- Amentum Holdings, Inc. Common Stock Operating income
- 503,000,000 USD
- Regeneron Pharmaceuticals, Inc. Operating income
- 3,577,900,000 USD